Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

October 28, 2025 03:00 ET | Source: Swarm Oncology Ldd

Swarm Oncology announces research collaboration with a leading hospital to advance T cell therapies for advanced solid cancers

London, United Kingdom October 28, 2025, Swarm Oncology Ltd. (“Swarm Oncology” or “Swarm”), a biotechnology company pioneering novel T cell therapies to achieve long-term remission in patients with...
May 08, 2025 02:00 ET | Source: Swarm Oncology Ldd

Swarm Oncology to present at Bio€quity Europe 2025

London, U.K., May 8 2025, Swarm Oncology Ltd. (“Swarm Oncology” or “the Company”), a biotechnology company pioneering novel T cell therapies to achieve long-term remission in patients with advanced...
January 27, 2025 03:00 ET | Source: Swarm Oncology Ldd

Swarm Oncology Unveils Highly Differentiated, Personalised T Cell Therapy Platform to Significantly Improve Treatment Outcome for Cancer Patients and Appoints Martin Olin as Chief Executive Officer

Swarm Oncology co-founded by renowned T cell therapy manufacturing expert and immunologist Professor John Campbell, and mission-driven investor, Delin VenturesCompany is developing novel potent T cell...
May 30, 2018 09:30 ET | Source: Symphogen A/S

Symphogen Further Strengthens its Immuno-Oncology Pipeline by Advancing into Two Additional Clinical Trials

Symphogen Further Strengthens its Immuno-Oncology Pipeline by Advancing into Two Additional Clinical Trials Seventh Program to enter Clinical Development at Symphogen Symphogen’s antibody platform is...